Advertisement
Organisation › Details
5 Prime (Group)
Start | 2007-11-01 existent | |
End | 2017-08-23 merged | |
Group | Qiagen (Group) | |
Today | Qiagen (Group) | |
Predecessor | Eppendorf 5Prime Inc. | |
Successor | Qiagen (Group) | |
Industry | reagents (bio/biochemical) | |
Industry 2 | oligo synthesis | |
Person | von Braunmühl, Benedikt (Rentschler 202309– CEO before HMNC Brain Health + Medicover AB + Qiagen + Chiron Vaccines) | |
Person 2 | Backheuer, Axel (5 Prime GmbH 201105 Managing Director) | |
Region | Hamburg | |
Country | Germany | |
Street | 4a Königstr. | |
City | 22767 Hamburg | |
Tel | +49-40-3197927-0 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2023-12-30 |
Advertisement
More documents for Qiagen (Group)
- [1] Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo....
- [2] Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh....
- [3] Qiagen N.V.. (9/25/23). "Press Release: Qiagen Enhances QIAwave Portfolio with New Eco-friendlier Nucleic Acid Extraction Kits". Venlo....
- [4] Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA....
- [5] Qiagen N.V.. (8/8/23). "Press Release: Qiagen Delivers Ahead of Outlook for Q2 2023 with 9% CER Sales Growth in Non-COVID Products and Updates 2023 Full-year Outlook". Venlo....
- [6] Qiagen N.V.. (8/7/23). "Press Release: Qiagen Receives FDA Approval for Companion Diagnostic to Blueprint Medicines’ Ayvakit (avapritinib) in Gastrointestinal Stromal Tumors". Venlo & Germantown, MD....
- [7] Qiagen N.V.. (7/26/23). "Press Release: Bio-Rad and Qiagen Announce Patent Settlement and Cross-licensing Agreement". Venlo....
- [8] Qiagen N.V.. (6/15/23). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Shows Unique Clinical Value with CD8 Technology in New Meta-analysis of Tuberculosis Screening". Venlo....
- [9] Qiagen N.V.. (6/13/23). "Press Release: Danish National Genome Center Selects Qiagen for Variant Interpretation in Oncology Genome Sequencing". Venlo & Redwood City, CA....
- [10] Qiagen N.V.. (5/15/23). "Press Release: Qiagen Expands Enzyme Offering to Support Individual Life Science Research Labs Worldwide". Berlin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top